Staff Scientist at Fred Hutch Cancer Center, United States
Jasmine Naru is a dedicated biological researcher with a robust background in various biological disciplines, including proteomics, molecular biology, biochemistry, and genetics. She earned her Ph.D. in Biochemistry from Panjab University, India, in 2016, and has since been associated with prestigious research institutions. Currently a Staff Scientist at the Fred Hutchinson Cancer Center in Seattle, WA, Jasmine has contributed significantly to the field of cancer research, particularly focusing on acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Her innovative research approaches aim to enhance risk stratification and therapeutic targeting for these conditions. Jasmine’s work has resulted in multiple publications in high-impact journals, showcasing her expertise and commitment to advancing the understanding of cancer biology.
Professional Profile
Education
Jasmine Naru’s educational journey reflects her commitment to biological research and academic excellence. She completed her Bachelor of Science in Life Sciences with a focus on Zoology, Botany, and Chemistry at Guru Nanak Dev University in 2006. She pursued her Master of Science in Human Genetics, graduating in 2008 from the same institution. Jasmine then advanced her studies at Panjab University, where she earned her Ph.D. in Biochemistry in 2016. Her doctoral research focused on protein profiling in retinoblastoma patients, utilizing mass spectrometry-based proteomics to identify potential biomarkers. This solid educational foundation has equipped her with the necessary knowledge and skills to excel in her research endeavors.
Professional Experience
Jasmine Naru has gained extensive professional experience in the field of biological research. She began her career as a Junior Research Fellow at the Post Graduate Institute of Medical Education and Research (PGIMER) in India in 2010. Her journey continued at Panjab University, where she served as a Junior and Senior Research Fellow until 2016. Following her academic tenure, Jasmine transitioned to the Fred Hutchinson Cancer Center in Seattle as a Postdoctoral Research Fellow, focusing on innovative cancer research projects from 2017 to 2023. Recently, she has taken on the role of Staff Scientist at Fred Hutch, where she develops novel approaches for risk stratification and therapeutic targeting in AML and MDS. Her professional trajectory showcases her dedication to advancing cancer research and her ability to lead impactful projects.
Research Interests
Jasmine Naru’s research interests are centered on advancing the understanding of hematological malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). She focuses on the development of innovative strategies for risk stratification and targeted therapy, employing proteomic and genomic approaches to identify novel biomarkers that can enhance patient outcomes. Her work encompasses the use of iPSC-derived cell lines to explore the biology of MDS and the development of immunotherapy techniques for myeloid malignancies. Jasmine is passionate about translating her research findings into clinical applications that can significantly improve the lives of patients facing these challenging diseases, making her a valuable contributor to the field of cancer research.
Research Skills
Jasmine Naru possesses a comprehensive set of research skills that enhance her capabilities as a biological researcher. Her technical proficiency includes advanced techniques in proteomics, such as mass spectrometry (ESI-MS/MS, MALDI-TOF/TOF), as well as quantitative analysis methods like iTRAQ and TMT. Jasmine is adept at using bioinformatics tools for pathway analysis and has experience in various molecular biology techniques, including PCR, ELISA, Western blotting, and flow cytometry. Additionally, she has strong analytical skills, enabling her to interpret complex data effectively. Jasmine’s multitasking abilities and collaborative approach allow her to thrive in fast-paced research environments, making her an asset to any scientific team.
Awards and Honors
Throughout her academic and professional career, Jasmine Naru has received several honors and recognitions for her contributions to the field of biological research. Notably, she was awarded the Junior Research Fellowship from the Indian Council of Medical Education and Research (ICMR) during her early research career, which provided her with essential support to pursue her doctoral studies. Her commitment to excellence is reflected in her successful publication record, with multiple first-author articles in high-impact journals. Jasmine’s research efforts have also been acknowledged through various project grants, such as the SWOG Impact Award and NIH/NIDDK funding, highlighting her contributions to advancing cancer research and her potential for future impactful work.
Conclusion
Overall, Jasmine Naru is a strong candidate for the Best Researcher Award. Her exceptional research experience in oncology, strong technical skills, and noteworthy publication record make her a highly deserving contender. Expanding her work’s breadth and obtaining more independent funding could further solidify her position as a top researcher in her field. Her dedication and scientific contributions already position her as a standout researcher with a clear impact in the scientific community.
Publication Top Note
- Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
- Authors: Pogosova-Agadjanyan, E.L., Hua, X., Othus, M., Meshinchi, S., Stirewalt, D.L.
- Year: 2023
- Journal: Biomarker Research
- Volume: 11
- Issue: 1
- Page: 31
- Citations: 0
- Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
- Authors: Termini, C.M., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
- Year: 2023
- Journal: Haematologica
- Volume: 108
- Issue: 11
- Pages: 3148–3151
- Citations: 2
- Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
- Authors: Clough, C.A., Pangallo, J., Sarchi, M., Bradley, R.K., Doulatov, S.
- Year: 2022
- Journal: Blood
- Volume: 139
- Issue: 13
- Pages: 2038–2049
- Citations: 44
- AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: A SWOG report
- Authors: Pogosova-Agadjanyan, E.L., Moseley, A., Othus, M., Meshinchi, S., Stirewalt, D.L.
- Year: 2020
- Journal: Biomarker Research
- Volume: 8
- Issue: 1
- Page: 29
- Citations: 23